Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Closes $235M Offering; Will Pay Off Debt Tied to Lumigen Buy

NEW YORK (GenomeWeb News) — Beckman Coulter closed its tender offer for $235 million in senior notes at the end of business yesterday, the company said today.
 
The company said the money raised from the offering would go toward paying debts, a large chunk of which coming from the acquisition of Lumigen, and it would use the rest of the funds to pay debts and fund research.
 
The 7.45-percent notes are due 2008, and were offered on Dec. 11 as part of a $600 million offering.
 
Beckman said it intends to pay a purchase price of $1,025.74, plus $21.94 in interest, per every $1,000 in notes purchased after the offer, and plans to redeem $4.9 million in outstanding notes after indenture.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.